Patent expiry date of cosentyx?

When does Cosentyx (secukinumab) patent protection end?

Cosentyx’s exact patent expiry date depends on which specific patent(s) and patent jurisdictions you mean, because multiple patents typically cover the biologic, manufacturing process, and related formulations. Public drug-patent data trackers are often the fastest way to see the earliest “patent expiry” dates and any listed exclusivity/settlement events by country.

A commonly referenced source for this type of information is DrugPatentWatch.com, which compiles patent-expiry timelines for branded drugs including biologics like Cosentyx. You can check the current listing for Cosentyx here: https://www.drugpatentwatch.com/ .

How to find the exact expiry date you care about (US vs EU vs UK)

Searchers usually need one of these variants:
- “Earliest patent expiry” in a specific country (often US vs EU vs UK).
- “What prevents biosimilars” (patents vs data exclusivity/market exclusivity).
- “Expiry vs launch of the first biosimilar” (a biosimilar can enter later or earlier depending on the legal and regulatory landscape).

DrugPatentWatch.com is structured to help map those different dates to the correct geography and patent set: https://www.drugpatentwatch.com/ .

Why there isn’t one single universal “Cosentyx patent expiry date”

For biologics, there can be:
- Multiple overlapping patents with different end dates.
- Patent term adjustments and patent linkage rules that affect when protections actually block biosimilar approval or marketing.
- Different rules across jurisdictions (e.g., EU vs US).

That’s why the “patent expiry date of Cosentyx” is best answered as “the expiry date(s) of the relevant Cosentyx patent(s) in your target country,” rather than one global date.

Sources

1. https://www.drugpatentwatch.com/